Eagles owner gifts $50M to CHOP and Penn Medicine to open the Lurie Autism Institute
Develop a better understanding of the genetics and complex biological processes underlying autism, including the role of environmental and epigenetic factors in its development;
Uncover how the diverse behaviors among the autism spectrum manifest and evolve across the lifespan;
Develop more advanced lab models to understand how autism impacts brain function across the lifespan;
Explore why some individuals with autism have minimal speaking ability, using insights from brain and language science;
Use AI to analyze large-scale biological and behavioral data to identify new treatment targets and existing drugs that may be repurposed for ASD.
Conduct research to study autism-related genes and their potential as therapeutic targets;
Prepare to launch clinical trials that prioritize both behavioral and pharmacological interventions for ASD.
Launch the Next-Generation Program in Autism Bioscience, a certificate program for PhD trainees and postdocs;
Serve as global conveners for the best ideas in the field by hosting an annual International Symposium and awarding the new Lurie Autism Institute Prize for ASD Research.
Lurie announced the launch of the Lurie Autism Institute this morning. This unique center will be the first-of-its-kind institute, located in Philadelphia, and aims to be a global hub for autism research and care.
'We established the Lurie Autism Institute to spark a new era of scientific discovery in autism. CHOP and Penn Medicine bring unmatched expertise and a proven record of innovation, and together, they have the tools to unlock answers that have eluded the field for far too long,' said Jeffrey Lurie, Chairman and CEO of the Philadelphia Eagles and founder of the Eagles Autism Foundation. 'By investing in cutting-edge science and the infrastructure to move it forward, we're aiming not just to understand autism more deeply—but to transform what's possible for individuals and families worldwide.'
Powered by Penn Medicine and CHOP's long history of partnering on transformative breakthroughs for the care of both children and adults, the Lurie Autism Institute is poised to make fresh discoveries that will reshape how we understand and treat autism.
This article originally appeared on Eagles Wire: Eagles owner donates $50M to open the Lurie Autism Institute
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
4 hours ago
- Business Wire
LinusBio and Coralis Health Partner to Reduce Autism Diagnosis Waitlists
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)-- LinusBio, a leader in precision exposome medicine, and Coralis Health, a pioneering virtual care platform for neurodivergent children and families, today announced a partnership to provide comprehensive end-to-end diagnostic services for autism spectrum disorder (ASD). This collaboration combines LinusBio's breakthrough ClearStrand-ASD ™ biomarker test with Coralis Health's specialized care platform, creating a seamless pathway from early screening to diagnosis and intervention. "This partnership represents exactly the kind of innovation needed to transform autism care.' - Dr. Manish Arora, founder and CEO, LinusBio The partnership addresses a critical gap in autism diagnosis and care by connecting families who receive ClearStrand-ASD results indicating potential autism risk directly to Coralis Health's network of specialized clinicians and diagnostic services, dramatically reducing the typical years-long diagnostic journey to just 90 days. Once ClearStrand results are available, LinusBio directly refers qualifying families to Coralis Health, with virtual diagnostic teams reaching out within five calendar days to schedule intake appointments and complete comprehensive evaluations within 90 days. The integrated service is designed primarily for families who have concerns about their child's development and are seeking both objective screening insights and expert diagnostic evaluation. Healthcare and service providers can also leverage this streamlined pathway to offer their patients a comprehensive diagnostic solution that reduces referral complexity and wait times for specialized autism evaluations. Streamlining the Path to Diagnosis and Care Evidence shows that early diagnosis and intervention are crucial for improved outcomes, yet many families still encounter lengthy delays in accessing the diagnostic support they need. Currently, families concerned about autism often face years-long waitlists for diagnostic evaluations, delaying access to crucial early interventions. This new partnership creates a direct bridge between biomarker screening and comprehensive virtual diagnostic services, significantly reducing the time between initial concern and professional evaluation. "This partnership represents exactly the kind of innovation needed to transform autism care," said Dr. Manish Arora, founder and CEO of LinusBio. "ClearStrand-ASD provides families with crucial early insights, but we recognized that many families needed additional support navigating the next steps. By partnering with Coralis Health, we're creating a comprehensive solution that takes families from screening through diagnosis and into intervention—all through a single, coordinated pathway." This partnership represents a significant expansion of LinusBio's service ecosystem, ensuring that families who receive ClearStrand-ASD results indicating autism risk have immediate access to the specialized care they need. Rather than simply providing test results, LinusBio is now able to guide families through the initial screening and facilitate connecting families into their diagnostic journey. "Our goal has always been to make sure that children are connected to life-changing therapies in a timely manner, while providing the highest quality care. We also want to reduce the burden on clinicians, by finding ways to standardize care in a space that's currently too dependent on individual clinical expertise and training," explained Dr. Ayesha Cheema-Hasan, founder and CEO of Coralis Health. "By leveraging technology thoughtfully, we aim to bridge the gap in access, and ensure that every child has the opportunity to thrive regardless of where they start." Comprehensive End-to-End Support The integrated service provides families with a complete diagnostic solution, from initial biomarker screening through comprehensive autism evaluation. Coralis Health's diagnostic team conducts thorough assessments using clinically validated tools, delivering detailed diagnostic reports that families can use to access essential services and interventions. The service is available for children 16 months and older, with younger children who complete ClearStrand testing receiving a credit toward future diagnostic evaluation once they meet the age requirement. The ClearStrand-ASD and diagnostic evaluation solution is a distinct offering, and is now available in 11 states; Alaska, Colorado, Connecticut, Illinois, Maryland, North Carolina, Rhode Island, Tennessee, Virginia, Washington and Washington, D.C. Families who receive ClearStrand-ASD results indicating potential autism risk will have direct access to Coralis Health's diagnostic services. About ClearStrand-ASD ClearStrand-ASD is a biochemical test intended to help health care providers rule out autism spectrum disorder (ASD) in children 1 to 48 months. The test analyzes a strand of hair to map the dynamic patterns of an individual's unique biological responses at a molecular level to environmental exposures over time and uses an algorithm to assess the likelihood of autism. It is not a genetic test and must be ordered by a licensed health care provider (Rx only). ClearStrand-ASD is performed at LinusBio's CLIA-certified laboratory (CLIA #31d2307499). For more information visit: About LinusBio LinusBio is a leader in precision exposome medicine, pioneering the use of temporal exposome sequencing to understand how environmental exposures influence health and disease over time. The company's proprietary platform produces 150 million biochemical data points from a single strand of hair, revealing molecular signatures that support earlier diagnosis and more personalized treatment approaches. Founded by leading exposome researchers from the Icahn School of Medicine at Mount Sinai, LinusBio is advancing biomarker research across multiple therapeutic areas, with a focus on neurodevelopmental conditions like autism. For more information, visit About Coralis Health, LLC Coralis Health, LLC is a first-of-its-kind platform to connect neurodivergent and disabled children, adults, and caregivers with highly specialized, world-class healthcare providers, therapies, and services. Our care spans all ages, starting from the initial concerns and diagnosis, all the way through adulthood. Founded on the belief that every person should have the opportunity to realize their full potential, Coralis Health is the future of developmental pediatrics and behavioral health. To learn more, please visit
USA Today
a day ago
- USA Today
Saquon Barkley says he's not a member of President Trump's Council on Sports Nutrition
Eagles All-Pro RB says he is not joining Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trump's Council on Sports, Fitness, and Nutrition.' In a move that will revive a standard from the Reagan, Clinton, and Bush era, Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor will join President Trump's Council on Sports, Fitness, and Nutrition.' One athlete and sports star who won't be participating is Eagles' All-Pro running back Saquon Barkley. Following Monday's practice, Barkley disputed the initial press release, stating that he will not be a member of the presidential council. According to the Washington Post, President Trump on Thursday announced that the presidential fitness test, a hallmark of American physical education programs, will be making a comeback in public schools. The assessment was retired and replaced by a fitness program under the Obama administration. The presidential fitness test was initiated in the 1950s by a council established by President Dwight D. Eisenhower that was directed to improve the physical fitness of American youths, in response to fears they were falling behind their European counterparts when it came to athleticism. The project is an alternative way to get anti-obesity drugs to Medicare and Medicaid patients, after the administration said in April that neither program would cover GLP-1s for weight loss. In doing so, it scrapped a 2024 Biden administration proposal for the programs to start covering GLP-1s for patients with obesity. Several high-profile athletes — all of whom have existing ties to Trump — attended the ceremony and will serve on the President's Council on Sports, Fitness and Nutrition. The attendees included professional golfer Bryson DeChambeau, who will chair the council; controversial National Football League kicker Harrison Butker; World Wrestling Entertainment mainstay Paul 'Triple H' Levesque; golfer Annika Sorenstam; and football Hall of Famer Lawrence Taylor. The Eagles running back wasn't in attendance and said he was shocked to hear his name mentioned. The list also includes NFL Commissioner Roger Goodell, whom Trump repeatedly scrutinized during his first presidential term. Barkley was criticized during the off-season for spending time with President Trump on a golf outing prior to the Eagles' ring celebration.
USA Today
4 days ago
- USA Today
Saquon Barkley among NFL stars who will join President Trump's council on Sports Nutrition
Eagles running back Saquon Barkley will join Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trumps Council on Sports, Fitness, and Nutrition.' Saquon Barkley is a son, a fantastic father, the NFL's Offensive Player of the Year winner, and now a member of President Donald Trump's administration. In a move that will revive a standard from the Reagan, Clinton, and Bush era, Barkley will join Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trump's Council on Sports, Fitness, and Nutrition.' According to the Washington Post, President Trump on Thursday announced that the presidential fitness test, a hallmark of American physical education programs, will be making a comeback in public schools. The assessment was retired and replaced by a fitness program under the Obama administration. The presidential fitness test was initiated in the 1950s by a council established by President Dwight D. Eisenhower that was directed to improve the physical fitness of American youths, in response to fears they were falling behind their European counterparts when it came to athleticism. The project is an alternative way to get anti-obesity drugs to Medicare and Medicaid patients, after the administration said in April that neither program would cover GLP-1s for weight loss. In doing so, it scrapped a 2024 Biden administration proposal for the programs to start covering GLP-1s for patients with obesity. Several high-profile athletes — all of whom have existing ties to Trump — attended the ceremony and will serve on the President's Council on Sports, Fitness and Nutrition. The attendees included professional golfer Bryson DeChambeau, who will chair the council; controversial National Football League kicker Harrison Butker; World Wrestling Entertainment mainstay Paul 'Triple H' Levesque; golfer Annika Sorenstam; and football Hall of Famer Lawrence Taylor. The Eagles running back wasn't in attendance, but will be joined by golfers Jack Nicklaus, Nelly Korda, and Gary Player (who was also awarded the Medal of Freedom alongside Sorenstam); Tony Romo, Nick Bosa, and Barkley; legendary hockey player Wayne Gretzky; and baseball player Mariano Rivera. The list also includes NFL Commissioner Roger Goodell, whom Trump repeatedly scrutinized during his first presidential term. Barkley was criticized during the off-season for spending time with President Trump on a golf outing prior to the Eagles' ring celebration.
